Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Broadway Treatment Center Incorporates Probuphine Implant to Addiction Treatment Program
  • USA - English


News provided by

Knack Media

Jun 21, 2016, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Broadway Treatment Center
Broadway Treatment Center
Youtube
Youtube

Probuphine helps with a long-term treatment alternative that can provide benefits to many patients suffering from this disease.

Post this

Orange, California (PRWEB) June 21, 2016 -- Broadway Treatment Center has consistently added therapies that assist those in recovery for those suffering from drugs or alcohol abuse. “We have begun the process of securing a trained and certified doctor to perform the procedure for clients who decide that it’s a good option for them” stated Kevin Leonard, Broadway Treatment Center’s Director of Marketing. Probuphine is the only FDA approved implant available that delivers and maintains safe levels of buprenorphine, its active ingredient, to the recipient around the clock, for up to six months at a time. It’s recommended for use in patients who are currently stable on low-to-moderate doses of other forms of buprenorphine, and should be used in conjunction with a comprehensive addiction treatment program for best results. To learn more about Probuphine implants in Orange County California call (714) 443 8218.

The current epidemic of opioid addiction is running rampant and unchecked across the country like a cancer. State and federal officials as well as treatment professionals, are scrambling to find ways to provide access to safe and effective treatment options for their constituencies. It’s been challenging to find viable medication options for people struggling with opioid addiction. It’s a double edged sword, given the possibility that an individual could easily become cross dependent on the substance that is intended to help them remain abstinent.

Buprenorphine, a partial opioid agonist, has been the gold standard in the treatment of opioid addiction. In proper dosages, it can suppress symptoms of opioid withdrawal, decrease cravings, and block the effects of opioids. The main goal being to help clients to stay in recovery longer and greatly decrease the chance of relapse while they work to build the skills needed to live a clean and sober lifestyle. Contact one of the top opioid addiction treatment centers orange county has to offer by calling Broadway Treatment Center and speak with an adviser to discuss treatment options.

Buprenorphine has previously been available in pill or sublingual film forms, but many have found issues that arise with these methods. Patients can forget to take their medication, or they end up taking too much or not enough, and there is always the possibility of loss or theft of the medication. The implant looks to mitigate these risks and will play an increasingly important role in the treatment of patients suffering from opioid addiction. Probuphine is an implant, and circumvents the usual shortcomings of other Buprenorphine delivery options, greatly reducing the risk of overdose, misuse and dependence.The new implant also gives hope for those searching for options to get off methadone or Vivitrol shots.

Probuphine is an implant, and therefore keeps the low-dose of medication constant and steady. There is no fluctuation, which greatly decreases the risk of overdose or dependence. The implant option also nulls the issue of the patient forgetting to take their medication daily, or the risk that it may be lost, or stolen. One implant session of Probuphine lasts for six months, making it convenient for patients who can tolerate and are already successfully on buprenorphine. Broadway Treatment Centers is pleased to be able offer Probuphine, the first FDA approved buprenorphine implant as an additional treatment option for their clients. In combination with counseling and other behavioral therapies, Probuphine is sure to be a staple in helping their opioid addicted clients succeed in long term recovery.

“The addition of the Probuphine implant is in line with our mission; being able to provide myriad treatment alternatives, whether it is medicinal, experiential, or educational, we are always looking for new ways to solve old problems” stated Shaun Lennert, Chief Operations Officer at Broadway Treatment Center. “We see the new implant as a viable alternative to traditionally available medication options, and are eager to be part of the solution.”

Broadway Treatment Center has been a leader and vanguard in the treatment of addiction, offering traditional, contemporary, and alternative techniques to their clientele. The Huntington Beach drug and alcohol rehab facility offers treatment programs to everyone from heroin addicts to alcoholics, across the continuum of care. Broadway was one of the first to incorporate pet-friendly services that encourages clients to bring their pets to treatment, as well as a couples therapy program that enables couples a chance to get clean and sober together.

For more information on Broadway Treatment Center:
info(at)broadwaytreatmentcenter(dot)com
http://www.broadwaytreatmentcenter.com
(714) 443-8218

Mason Baxter, Knack Media, http://www.knackmedia.com, +1 (877) 957-2244, [email protected]

Modal title

Broadway Treatment Center
View PDF
Broadway Treatment Center
Broadway Treatment Center

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.